v3.26.1
Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and due from banks $ 6,879 $ 7,738
Interest bearing deposits with banks 103,995 149,125
Cash and cash equivalents 110,874 156,863
Investment securities available for sale, at fair value 4,366 4,746
Investment securities held to maturity, net of allowance for credit losses 8,760 8,777
Total investment securities 13,126 13,523
Loans, net of unearned income 2,043,296 2,035,227
Less: Allowance for credit losses (34,921) (34,649)
Net loans 2,008,375 2,000,578
Accrued interest receivable 11,504 11,257
Premises and equipment, net 5,462 5,506
Restricted stock 8,566 8,085
Bank owned life insurance (BOLI) 35,541 35,320
Deferred tax asset 10,720 10,719
Other real estate owned (OREO) 2,862 2,862
Other 5,905 4,723
Total assets 2,212,935 2,249,436
Deposits    
Noninterest-bearing deposits 164,105 196,506
Interest-bearing deposits 1,534,639 1,562,163
Total deposits 1,698,744 1,758,669
FHLBNY borrowings 140,000 130,000
Subordinated debentures 13,403 13,403
Accrued interest payable 4,650 4,575
Other 20,575 18,271
Total liabilities 1,877,372 1,924,918
Shareholders' Equity    
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 325 shares outstanding at March 31, 2026 and December 31, 2025 325 325
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 12,515,472 shares and 12,425,768 shares at March 31, 2026 and December 31, 2025, respectively 1,252 1,243
Additional paid-in capital 140,587 139,268
Retained earnings 207,391 197,671
Accumulated other comprehensive loss (203) (200)
Treasury stock, 784,522 shares at March 31, 2026 and December 31, 2025, at cost (13,789) (13,789)
Total shareholders’ equity 335,563 324,518
Total liabilities and shareholders' equity $ 2,212,935 $ 2,249,436